Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Spencer

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Current Opinion in Obstetrics & Gynecology|August 29, 2022
The treatment of endometriosis-associated infertilityStuart Spencer, Alexandros Lazaridis, Alexandros Grammatis, et al.
Current Opinion in Obstetrics & Gynecology|July 27, 2022
Nonsurgical management of adenomyosis: an overview of current evidenceAlexandros Lazaridis, Alexandros L Grammatis, Stuart Spencer, et al.
Studies in Health Technology and Informatics|August 12, 2015
Data Science Solution to Event Prediction in Outsourced Clinical Trial ModelsDaniel Dalevi, Susan Lovick, Helen Mann, et al.
Clinical Colorectal Cancer|December 21, 2013
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I studyJair Bar, Stuart Spencer, Shethah Morgan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapyIgnacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.
The Lancet. Oncology|June 6, 2013
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised studyCaroline Robert, Reinhard Dummer, Ralf Gutzmer, et al.
European Heart Journal|May 11, 2023
Rapid, accurate publication and dissemination of clinical trial results: benefits and challengesFaiez Zannad, Filippo Crea, John Keaney, et al.
Cancer|April 11, 2016
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapyUrsula A Matulonis, Philipp Harter, Charlie Gourley, et al.
British Journal of Cancer|November 9, 2016
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancerJonathan A Ledermann, Philipp Harter, Charlie Gourley, et al.
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Obstetrics & Gynecology|August 29, 2022
The treatment of endometriosis-associated infertilityStuart Spencer, Alexandros Lazaridis, Alexandros Grammatis, et al.
Current Opinion in Obstetrics & Gynecology|July 27, 2022
Nonsurgical management of adenomyosis: an overview of current evidenceAlexandros Lazaridis, Alexandros L Grammatis, Stuart Spencer, et al.
Studies in Health Technology and Informatics|August 12, 2015
Data Science Solution to Event Prediction in Outsourced Clinical Trial ModelsDaniel Dalevi, Susan Lovick, Helen Mann, et al.
Clinical Colorectal Cancer|December 21, 2013
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I studyJair Bar, Stuart Spencer, Shethah Morgan, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapyIgnacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.
The Lancet. Oncology|June 6, 2013
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised studyCaroline Robert, Reinhard Dummer, Ralf Gutzmer, et al.
European Heart Journal|May 11, 2023
Rapid, accurate publication and dissemination of clinical trial results: benefits and challengesFaiez Zannad, Filippo Crea, John Keaney, et al.
Cancer|April 11, 2016
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapyUrsula A Matulonis, Philipp Harter, Charlie Gourley, et al.
British Journal of Cancer|November 9, 2016
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancerJonathan A Ledermann, Philipp Harter, Charlie Gourley, et al.
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
Pageof 3